Clinical experience with ofloxacin in urinary tract infection. 1986

C E Cox, and S V Callery, and K J Tack

Preliminary data from the U.S. regarding the safety and efficacy of ofloxacin in the treatment of urinary tract infections are presented. Treatment of uncomplicated urinary tract infections with either 200 mg or 300 mg ofloxacin b.i.d. was as effective as treatment with a standard therapy, co-trimoxazole. In another series of patients with underlying abnormalities of the urinary tract, ofloxacin therapy resulted in fewer failures and relapses than co-trimoxazole treatment. Ofloxacin was well tolerated in these studies.

UI MeSH Term Description Entries
D008297 Male Males
D010078 Oxazines Six-membered heterocycles containing an oxygen and a nitrogen.
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D013420 Sulfamethoxazole A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208) Sulfamethylisoxazole,Gantanol,Sulfisomezole,Sulphamethoxazole
D014295 Trimethoprim A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported. Proloprim,Trimpex
D014551 Urinary Tract The duct which coveys URINE from the pelvis of the KIDNEY through the URETERS, BLADDER, and URETHRA. Tract, Urinary,Tracts, Urinary,Urinary Tracts

Related Publications

C E Cox, and S V Callery, and K J Tack
July 1988, Hinyokika kiyo. Acta urologica Japonica,
C E Cox, and S V Callery, and K J Tack
January 1990, Scandinavian journal of infectious diseases. Supplementum,
C E Cox, and S V Callery, and K J Tack
June 1988, Vnitrni lekarstvi,
C E Cox, and S V Callery, and K J Tack
May 1987, Hinyokika kiyo. Acta urologica Japonica,
C E Cox, and S V Callery, and K J Tack
March 1993, The American journal of medicine,
C E Cox, and S V Callery, and K J Tack
June 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
C E Cox, and S V Callery, and K J Tack
August 1985, Hinyokika kiyo. Acta urologica Japonica,
C E Cox, and S V Callery, and K J Tack
June 1990, Hinyokika kiyo. Acta urologica Japonica,
C E Cox, and S V Callery, and K J Tack
July 1989, Journal of chemotherapy (Florence, Italy),
C E Cox, and S V Callery, and K J Tack
January 1988, Drugs under experimental and clinical research,
Copied contents to your clipboard!